2 electron microscope, a Drosophila PRC1 subcomplex has been seen to compact nucleosome arrays in vitro (14) . A recent study revealed that a human PRC1 complex composed of Bmi-1, HPH2, PC3 and Ring proteins (Ring1A & Ring1B), which are homologs of Drosophila Psc, Ph, Pc and dRing, respectively, is an E3 ubiquitin ligase complex that mono-ubiquitinates lysine 119 of nucleosomal histone H2A (15) . The catalytic subunit of the PRC1 E3 ligase complex is Ring1B. The E3 ligase activity has been shown to be important for the involvement of PRC1 in Xchromosome inactivation and the control of Hox gene expression (16) (17) (18) (19) .
Very recently the mammalian PRC1 complex has been reconstituted using recombinant proteins (19) . It was shown that Bmi-1, a Drosophila Psc homolog that was originally discovered through its ability to collaborate with Myc in lymphomagenesis (20) (21) (22) , plays a central role in the assembly of the PRC1 complex and, while Bmi-1 displays no detectable ubiquitin ligase activity, the binding of Bmi-1 greatly stimulates the E3 ligase activity of Ring1B (15, 19) . To gain mechanistic insights into the assembly and enzymatic activity of the PRC1 complex, we have determined the structural requirements for the Bmi-1-Ring1B interaction and the basis for stimulation of the E3 ligase activity.
Materials and Methods

Protein expression and purification -Human
Ring1B and a Bmi-1 fragment encompassing residues 1 to 230, were overexpressed in E. coli as an untagged and a GST-fusion protein, and Ring1B (R70D) were generated by PCR and verified by DNA sequencing. The two proteins were co-expressed in the BL21(DE3) strain of E.
coli. Both the wild-type and mutant Bmi-1-Ring1B complexes were first purified on a glutathione-sepharose column. The GST tag was then removed by in-column digestion with the preScission protease and the eluted Bmi-1-Ring1B complex was further purified by hydrophobic and gel-filtration column chromatography using a phenyl-sepharose and a Superdex-200 (Pharmacia) column, respectively.
Domain mapping and mass analysis -The
Bmi-1-Ring1B complex eluted from the glutathione-sepharose column was subject to treatment with elastase at an approximately 1:100 (w/w) enzyme to protein ratio for two hours at room temperature. The stable Bmi-1-Ring1B core was then purified using the same procedure described above. The identities of the elastasedigested products were analyzed by mass spectrometry according to the following procedures: the samples was diluted directly into MALDI matrix (a saturated solution of 3-indole acrylic acid in 50% Acetonitrile, 0.1% acetic acid) and spotted directly onto the MALDI plate.
Spectra were acquired using an ABI 4700 in linear mode. Another aliquot of sample was reduced and alkylated using TCEP and iodoacetamide and then digested with trypsin for 6 hours in 50 mM diammonium phosphate (pH 8.0). Following digestion the sample was desalted using micro reverse phase columns, mixed with MALDI matrix and spotted directly onto the MALDI plate.
Spectra were acquired using an ABI 4700 and matching peptides were confirmed by MS/MS.
The resulting data were analyzed using the MASCOT search engine.
Ubiquitin E3 ligase assay -oligonucleosomes Crystallization and structure determination -
The elastase treated mini Bmi-1-Ring1B core was concentrated to ~20 mg/ml in a buffer containing 20 mM Tris at pH 8.0, 500 mM NaCl, 1mM
EDTA and 1.5 mM DTT for crystallization. The Table 1 .
The structure was solved by the MAD method. The positions of three Zn ions were located using the SOLVE program (24) . Phasing was carried out using the PHASES program suite (25) , and one additional Zn ions were identified using difference Fourier analysis. Model building was carried out using the graphic program O.
Refinement was initially carried out using REFMAC (26) of the CCP4 program suite (27) and the statistics are shown in Table 1 . Figures were prepared with the programs PYMOL (28) and GRASP (29). The PDB accession code is 2H0D. The summation is over all the observed reflections.
Results
Characterization of
b Phasing power = r.m.s. (<F H >/E), where F H is the calculated structure factor of the heavy atoms and E is the residual lack of closure.
c R-factor = Σ||F O | -|F C ||/Σ |F O |, where F O denotes the observed structure factor amplitude and F C denotes the structure factor calculated from the model.
